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Diabetes mellitus is the most common endocrine disorder. According to the American 
Diabetes Association (ADA), this disease afflicts more than 10 million persons in the United 
States alone. During the coming year, it is estimated that another 750,000 people will be 
diagnosed with this disease. Since 1932, Diabetes Mellitus (DM) has ranked among the 10 
leading causes of death in the United States. Given these statistics, it would only be wise to 
examine ways in which we can control and even prevent the onset of this debilitating disease. 
The medical community and some of the general public know that this disease can be 
controlled with medication and diet. Besides this, research has shown repeatedly that regular 
physical exercise can improve the health and disease status of diabetics, along with preventing the 
onset of the disease in others. (porte & Rifkin, 1990) In order to use this information to our 
benefit, we must make more of the public aware of this disease and the magnitude of it. 
I have examined this disease not only in the text books I have read but in real life 
situations. I have witnessed the effects of years of misunderstanding on the patient level. Yet, 
I have, also, seen the effects of proper medical treatment, education and regular aerobic exercise 
on the disease process. In an attempt to increase the awareness and knowledge that the general 
population has of this disease and the effects of regular aerobic exercise, I have decided to write 
the following paper on diabetes mellitus. 
Definitions and Classifications 
Diabetes mellitus (commonly called diabetes) can be associated, in general, by problems 
in the control of blood glucose levels that result in the elevated concentration of glucose in the 
blood (hyperglycemia) and problems in the regulation of insulin. (Porte & Rifkin, 1990) It 
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represents a syndrome of insulin deficiency that can caused as a result of heredity and/or 
environmental factors. Along with the more apparent hyperglycemia, other metabolic 
abnormalities are present that are linked with the hyperglycemia. Such abnormalities include 
disturbances in the metabolism carbohydrates, fats, and proteins often linked with absolute or 
relative deficiencies in insulin secretion and/or insulin action. 
Due to the search for more knowledge, more is being learned about diabetes and the 
disease process of it. One change that can be noted is the classification of the disease. A short 
time ago diabetes was grouped into two categories: juvenile diabetes and adult onset diabetes. 
However, the line between the two was not always cut and dry. It was difficult to determine what 
type of diabetes the patient had. A modification had to be made in the classification of diabetes, 
in order to more efficiently represent the disease type. This change resulted in the new 
classification of Type I, or insulin dependent (IDDM) and Type II, or non-insulin dependent 
(NIDDM). There are also more ways in which diabetes can be classified, but these are the major 
ones. 
IDDM, as the name implies, is dependent on insulin supplementation. This 
supplementation is necessary to avoid life threatening complications and maintain the life of the 
diabetic. This disease is often characterized by a sudden onset of symptoms that result from a 
deficiency of insulin production by the pancreas. (Huether & McCance, 1990) In IDDM, actual 
death of the beta cells in the islets of Langerhans is reported. (Arky, 1983) This, in tum, leads 
to a deficit in insulin production and action. This deficiency in insulin action leads to metabolic 
consequences. 
IDDM is likely to be categorized as having the more "classic" symptoms associated with 
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diabetes. These metabolic symptoms include excessive thirst (polydipsia), excessive urination 
(polyuria), unsatisfied hunger (polyphagia), weight loss, cessation of growth among the young, 
irritability, and drowsiness. (Pickup & Williams, 1994) Insulin is used in an effort to replace the 
insulin that is lacking in the body which helps to utilize the excess glucose. Uncontrolled diabetes 
can have such implications as glucose in the urine (glycosuria), excessive levels of glucose in the 
blood (hyperglycemia), and high levels of ketone bodies in the blood (ketosis). (Arky, 1983) 
Insulin is used to treat IDDM by replacing insulin levels and thus, utilizing the excess glucose. 
IDDM is the most prevalent form of diabetes among children and young adults. It can 
occur at any age, but is more widespread in the young. IDDM develops more frequently during 
adolescence with its peak onset being between the ages of 11-13 and then after the age of forty. 
Only about 10 % of all diabetic patients have this form of diabetes. 
Although the relationship between diabetes and heredity and the environment is still being 
examined, a link between race and the susceptibility of developing IDDM has been established. 
People of northern European origin are more likely to be diagnosed with IDDM. The di,case 
has a much lower incidence among people of Oriental or native American heritage. As far as 
heredity and IDDM, a clear correlation between the two has not yet been established. 
The second type of diabetes, which is classified as Type II (NIDDM), accounts for nearly 
90% of all diagnosed cases. (Nieman, 1995) NIDDM may have the classical symptoms 
associated with it, as in IDDM. However, it is more apt to be asymptomatic. An incidence of 
hyperglycemia in people with NIDDM is noted, also. Nevertheless, insulin treatment is not 
prescribed for the same reason as in IDDM. Rather, insulin treatment is used to control the 
glucose levels in the blood, and is not needed to maintain the life of the patient on an immediate 
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basis, as it is in IDDM. 
NIDDM results from impaired pancreatic beta cells and abnormalities on cell surfaces or 
within the cell which leads to diminished cell sensitivity to insulin. (Reference, 1989) Rather 
than actual death of the beta cells that is associated IDDM, only impairment is noted. This results 
in hyperglycemia and the other metabolic symptoms mentioned above. Unfortunately, the first 
signs of the disease may be such complications as neuropathy or atherosclerotic heart disease. 
There appears to be a more established link between heredity and NIDDM. However, the 
more apparent link seems to be between NIDDM and obesity. Nieman refers to this phenomenon 
as "diabesity". (1995) It has been shown that people who are 50% or more over their desirable 
body are five times more likely to be diabetics than those of normal weight. Frequently the 
diabetes may occur as a triad--hyperglycemia, obesity, and hypertension. (Pickup & Williams, 
1994) All of which present an increased risk for heart disease. Although obesity may intensify 
the cells' resistance to insulin and may precipitate hyperglycemia, NIDDM can develop in the 
absence of obesity. 
Pathophysiology 
Diabetes is a syndrome that encompasses many etiologies and abnormalities. Yet, they all 
share one common factor: hyperglycemia. Diabetic symptoms may result from insulin deficiency 
or from insulin resistance that renders insulin ineffective. The abnormality may be caused by one 
of many factors. Factors may include an abnormality in the beta cells in the islets of Langerhans, 
in the circulation, in the cell membrane, or in the target cells. (Huether & McCance, 1990) 
IDDM is usually marked by a defect in insulin secretion due to a dead or dying beta cell. 
NIDDM may result from a defect occurring at any point in insulin secretion, circulation, or 
, 
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peripheral action. (Pickup & Williams, 1994) 
In trying to understand the pathophysiology of diabetes, we must first be aware of what 
insulin is and does in the body. Insulin is a hormone secreted by beta cells in the islets of 
Langerhans in the pancreas. This hormone is responsible for regulating glucose levels in the 
body. It is also the primary hormone controlling the storage and metabolism of carbohydrates, 
proteins, and fats. The body stores and metabolizes nutrients largely through insulin's control, 
with glucose included. In diabetes, the impairment of carbohydrate metabolism often coexists 
with impaired fat and protein. 
After a meal, minimal insulin deficiency leads to elevated blood glucose levels because not 
enough of the hormone is available to enable cells to utilize the extra glucose. As in diabetics, 
severe insulin deficiency has the same effect. Without insulin, glucose cannot enter the cells. 
Since glucose is a major source of cell energy, the cells are deprived. They tum to other 
pathways of metabolism to meet their energy needs. Therefore, protein and fat breakdown occurs 
because of the lack of insulin. 
An acute insulin deficiency may lead to diabetic ketoacidosis (DKA) by altering 
carbohydrate, fat, and protein metabolic pathways. (Arky, 1983) If this is not corrected, DKA 
will progress to diabetic coma and death. However, IDDM is the type that is more likely to be 
linked with this progression. Yet, DKA is still a risk in NIDDM. Thus, it should not be taken 
lightly. 
Insulin is not the only hormone involved in diabetes. Other hormone frequently 
accompany the insulin deficiency. These hormones include glucagon, cortisol, catecholamines, 
and growth hormones. Each of these hormones counteracts the insulin and thus promotes 
F 
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hyperglycemia. Glucagon is the primary hormone involved with the insulin. The body does not 
stop secretion of this hormone even with low levels of insulin in the body. One would come to 
assume that because of the way the body works, hyperglycemia would suppress the secretion of 
glucagon. Due to the low levels of insulin in the body, the glucagon is not suppressed. 
Therefore, the insulin deficiency needs to be corrected by medical measures. Again, this type of 
insulin shortage is more commonly coupled with IDDM rather than NIDDM. 
As I mentioned before, insulin is produced by the beta cells in the islets of Langerhans. 
It has been shown that in people with diabetes the beta cells are in some way interrupted thus 
disturbing the production and secretion of insulin. (Osterby, 1983) It has been shown that in a 
person with IDDM the beta cells are destroyed. Although, hyperglycemia can occur, 80% to 90% 
of the insulin-secreting beta cells in the islets of Langerhans must be destroyed. (Huether & 
McCance, 1990) 
The destruction of the beta cells in IDDM is marked by a presence of islet cell antibodies 
(lCA). lCA is present in up to 85 % of newly diagnosed insulin dependent diabetics. (Pickup & 
Williams, 1994) Although the functional role of lCA has yet to be determined, it appears to play 
a role in the destruction of such tissues. lCA is only found in about 5 % of non insulin dependent 
diabetics. 
Other theories that explain the etiology of lDDM propose that it involves an immune 
reaction, a viral disease, or inherited susceptibility combined with environmental factors. Porte 
& Rifkin have shown that IDDM involves an autoimmune response that destroys the beta cells 
gradually. (1990) Although no direct evidence of such a mechanism exists, the stimulus is thought 




In contrast to IDDM, beta cells in NIDDM are not destroyed. They may still produce 
insulin, but they do so at a sluggish rate. Besides delayed insulin secretion, some subsets of 
NIDDM manifest insulin resistance in tissues such as muscle, liver and adipose tissue. 
As for NIDDM, the pathophysiology is not as clear. Although, the understanding of the 
pathogenesis of the disease has advanced considerably in the recent years. The pancreatic changes 
in NIDDM are nonspecific. NIDDM is usually caused by some gene-environmental interaction. 
In the diabetic with NIDDM an inherited secretory deficiency of insulin and an excess of glucagon 
may contribute to the disease process. However, the risk factor that is most closely associated 
with NIDDM is obesity. 
In the obese person, insulin has a decreased ability to influence glucose uptake and 
metabolism in the liver, skeletal muscles, and adipose tissue. Many theories have been proposed 
as to why the obese person is more likely to have an onset of NIDDM. These theories cover a 
great range of ideas. One theory states that a decreased number of insulin receptor sites on the 
plasma membrane will result in decreased insulin binding which results in a sensitivity to insulin. 
(Dunn, Petri, & Raskin, 1980) Another theory that more clearly states a relationship between 
diabetes and obesity is the one which implies that overeating leads to an increase in the insulin 
in the body which, in tum, necessitates the development of peripheral insulin resistance to protect 
against hyperglycemia. (Pickup & Williams, 1994) It is important to remember that obesity alone 
is insufficient to cause NIDDM. However, genetic predisposition and some impairment in the 
secretion of insulin is necessary for the development of NIDDM. In any case, the mechanism 
which is responsible for the cause of NIDDM may be reversed through weight loss. 
Complications Associated with Diabetes Mellitus 
r f 
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The diabetic person must take great care in the management of their disease. First and 
foremost, the diabetic must control their glucose levels through such means as diet, medication, 
and exercise. This is not an easy task to accomplish. As any diabetic can tell you, complications 
will arise. Most of the time they can be prevented, but one must be aware that they exist. 
There are two categories that exist: acute and chronic. Acute means that the complications 
are short term and almost always reversible with correct treatment, if identified correctly. 
Chronic complications, on the other hand, are generally long term and permanent. There are 
three main acute complications that arise from uncontrolled diabetes, of which include 
hypoglycemia, diabetic ketoacidosis, and hyperosmolar hyperglycemia nonketotic coma. (Nieman, 
1995) 
Hypoglycemia is a lowered blood glucose level. In general, hypoglycemia occurs when 
blood glucose levels fall below the level of 45-60 mg/dL. (porte & Rifkin, 1990) This can result 
from too much insulin, too little food or excessive physical activity. At low levels, the person 
may exhibit signs of impairment which may be physical and neurological. Due to the fact that 
the brain is dependent on the oxidation of glucose for energy, neurological symptoms are almost 
always present to some extent. When the blood glucose levels fall, the brain is unable to function 
and symptoms of hypoglycemia ensue. The symptoms are not the same for every individual, but 
they remain consistent for each person. The symptoms of hypoglycemia can range from pallor, 
tachycardia, sweating, nausea, anxiety, and hunger. In adults, sweating is often an especially 
prominent symptom of hypoglycemia. Neurologic symptoms have been identified, but not limited 
to blurred vision, headaches, behavioral changes, and disturbed mentation. Hypoglycemia may 
cause permanent neurologic damage. 
r f 
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Hypoglycemia is sometimes noticed in non-diabetics but is most often noticed in people 
with diabetes, particularly IDDM. In any case the safest treatment when hypoglycemic conditions 
occur is to provide some form of glucose. If this is not done, the person may experience 
convulsions, or go into a diabetic coma. The end result, if left untreated, could be death. 
Diabetic ketoacidosis is a condition that results from an insulin deficiency. Ketoacidosis 
most often occurs in stressful situations, such as infections, trauma, surgery, myocardial 
infarction, or emotional stress. Inadequate insulin levels in the blood and tissues sets off a chain 
of metabolic events .. 
The first effect of insulin deficiency is a decrease in the utilization of glucose. The 
outcome will be an accumulation of glucose in the blood due to the fact that the glucose can not 
enter the cell without insulin. When the accumulated glucose exceeds the renal threshold, it spills 
into the urine. The excess urine glucose acts as an osmotic diuretic. The final effect is increased 
thirst with dehydration following. 
At the same time, fats are broken down to supply energy to the glucose-starved cells, and 
a=lerated gluconeogenesis, reproduction of glucagon, is occurring. The problems lies with the 
rate at which the fatty acids are broken down compared to the rate at which they are utilized. 
Since the fatty acids are broken down faster than they can be used, ketones, end products of fat 
metabolism, form in the liver, accumulate in the blood stream and accelerate metabolic acidosis. 
Ordinarily, ketones used by the brain or skeletal muscles as an energy source will regenerate 
bicarbonates to counteract their acidity. However, the increase in ketones production causes a loss 
of bicarbonate and other body buffers, resulting in the subsequent development of metabolic 
acidosis. (Reference, 1989) Symptoms of DKA can include, but are not limited to Kussmaul 
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respirations (hyperventilations in an attempt to correct the acidosis), postural dizziness, central 
nervous system depression, and abdominal pain. (Arky, 1983) The best treatment for DKA is 
the administration of low-dose insulin in an attempt to lower blood glucose levels. 
Hyperosmolar hyperglycemic nonketotic coma (HHNK) is basically DKA without the 
ketoacidosis. In this condition, the patient has enough insulin to inhibit lipolysis. Unlike 
hypoglycemia and DKA, HHNK is typically observed inpatients with NIDDM. The condition is 
a life-threatening emergency with a high mortality rate. 
Chronic complications generating from years of diabetes are fairly common in the diabetic 
world. Before the discovery of long-term insulin, chronic complications were basically unheard 
of because of the short survival time. NOw, long-term survival is a rule. As a result, chronic 
complications have become important. There are many chronic complications that can be 
discussed, each with its own sub-division. Yet, the major ones in which I am going to address 
are diabetic neuropathy, microvascular disease, and macrovascular disease. These are the most 
common and widely noted complications. 
Although diabetic neuropathy is probably the most common complication in diabetes, it 
is very poorly understood. The overall presence of diabetic neuropathy is uncertain but appears 
to parallel the duration and severity of the hyperglycemia in both IDDM and NIDDM. It is rarely 
found before the fifth year of diabetes, except in NIDDM due its asymptomatic nature. It will 
ultimately effect up to 50% of patients with long term diabetes. 
Diabetic neuropathy affects many structures and gives rise to broad range of symptoms, 
including the common peripheral neuropathy. Peripheral neuropathy is the most abundantly noted 
type of neuropathy. This is also the most painful type of neuropathy. It affects all extremities, 
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most often the feet and the legs. Therefore, preventative management strategies seem to be the 
essential issue to be dealt with when considering neuropathy until more can be understood about 
the pathophysiology. 
Microvascular disease has a characteristic thickening of the capillary basement membrane. 
(Dunn, Petri, & Raskin, 1980) This thickening can emerge over a period of 1-2 years. The 
thickening eventually results in decreased tissue perfusion (passage of fluids through the vessels). 
In this case, the severity of the disease has not been linked with the development of the thickening 
of the basement membrane. The frequency to which these lesions develop does appear to be 
associated with the duration of the disease. 
Hypoxia (diminished availability of oxygen to the tissues) and ischemia (deficiency of 
blood due to functional constriction or actual obstruction of a blood vessel) of various organ often 
occurs from microangiopathy. (Arky, 1983) The two areas most often affected are the retina and 
the kidneys. Retinal ischemia has different stages and can develop in both IDDM and NIDDM. 
It is a progressive process that can result in retinal detachment or hemorrhage in the eye. If the 
ischemia occurs near the fovea in the eye, severe loss of vision may result which could lead to 
inevitable blindness. With regards to the kidney, it loses it's ability to metabolize insulin along 
with other renal functions because of the thickening of the glomerular basement membrane. This 
eventually leads to complications which may lead to kidney failure. This is more common in 
IDDM than in NIDDM. 
Macrovascular disease is the most prominent, overall cause of morbidity and mortality 
among individuals with NIDDM. Unlike microvascular disease, macrovascular disease is 






Macrovascular disease, often referred to as atherosclerotic disease, is a condition 
characterized by degeneration or hardening of the walls of the arteries and sometimes the valves 
of the heart, related especially to the thickening of the walls of the arteries. Changes in the vessel 
walls consist of deposits of platelets, smooth muscle cells, lipids, cholesterol, and calcium. 
Although this occurs in both the diabetic and the non-diabetic, it is quantitatively greater in the 
diabetic person. 
Other important differences between the diabetic and the non-diabetic are very common 
for this disease process. The atherosclerotic disease is more common among diabetics. It appears 
at a younger age, progresses more rapidly, and is almost as common in women as it is in men. 
In the non-diabetic, the disease is more common in men than in women. 
Other important differences include the vessels involved and the extent of the involvement. 
In the diabetic, more vessels are affected with a greater severity than in the non-diabetic. There 
is an increased incidence of peripheral vascular disease among diabetics. It is often the cause for 
amputation of the extremities. 
The prevalence for coronary heart diease (CHD) is high among diabetics. In the coronary 
arteries of patients with diabetes, there appears to be a greater narrowing of the left main coronary 
artery, a greater number of major coronary arteries involved, and a greater dispersement in the 
distribution of the atherosclerotic lesions. (Beamish, Dhalla & Pierce, 1988) Diabetics with 
NIDDM account for the majority of cases of atherosclerotic disease. However, it is not limited 
I ! to this type. 
In general, the prevalence of the known major risk factors for CHD is amplified in 
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diabetics. The major risk factors that are of particular importance are lipoprotein concentration 
and composition (dyslipidemia), hyperinsulinemia, hypertension, and obesity.(Nieman, 1995) 
CHD in diabetic patients is associated with increased cholesterol levels in the blood, with reduced 
high density lipoprotein cholesterol (HDL) in NIDDM patients, and with increased triglyceride 
levels. 
The most common lipid abnormality is increased triglycerides due to excessive 
concentrations of very low density lipoprotein cholesterol (VLDL). Triglycerides is related, in 
part, to the degree, duration, and control of the diabetes. The level of triglycerides in the blood 
plasma has been shown to decrease and return to normal levels after intensified insulin treatment. 
In patients with NlDDM, HDL levels are reduced along with the increase in triglycerides. 
HDL is a form of cholesterol that helps to combat the onset of CHD and are thought to be a 
protective mechanism. Research has shown that the level of HDL-cholesterol was inversely 
related to CHD. Therefore, it would be beneficial to have a high level of HDL-cholesterol. 
Another risk factor that is associated with CHD and diabetes is hypertension. 
Hypertension is more widespread among those people with IDDM and NIDDM. In NIDDM, 
hypertension can occur as a part of a syndrome in which it can coexist with obesity, insulin 
resistance, and dyslipidemia. It is thought that hypertension may be a result of the resistance in 
the blood vessels of diabetic patients. It has also been speculated that due to the mechanism of 
the disease there is an increase in extracellular fluid an d sodium which contributes to 
hypertension. 
Hypertension has been associated with nephropathy. Researchers are still not certain as 






is clear, however, that nephropathy accelerates hypertension and that hypertension accelerates the 
nephropathy. 
NIDDM is most commonly associated with obesity, and obesity has also been linked to 
hypertension. There are many factor that correlate hypertension, obesity, and diabetes. High 
blood pressure is three times as common among the obese than it is in people who are not obese. 
In addition, diabetes is nearly three times as high among the obese. This is yet another reason that 
diabetics have an increased incidence of coronary heart disease. 
Effects of Exercise 
Physical activity is now establishing a place in the world of health. The list of the benefits 
of exercise is constantly lengthening. Research is still being performed that is showing the 
benefits of regular physical activity on diabetes and more specifically, on glucose control. Along 
with proper diet and weight reduction, exercise is being recommended for the management of 
diabetes, especially NIDDM. 
Exercise has long been seen as helpful in controlling NIDDM. The major effects of 
exercise on NIDDM include the lowering of insulin levels after exercise, increasing HDL-
cholesterol levels, and increasing sensitivity to insulin. (Arky, 1983) It appears that decreased 
pancreatic secretions of insulin result in the lower insulin levels. Glucose utilization is enhanced 
by exercise and thus the level of glucose in the body drop. This drop is often seen even after the 
exercise is discontinued. 
Insulin sensitivity in the cells is lost with the onset of NIDDM. Exercise has been found 
to increase the sensitivity to insulin due to the decrease in insulin production. However, this 
exercise must be constant to produce an improvement in the insulin sensitivity. It has been shown 
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that the advantage is rapidly lost if the exercise is discontinued. Each exercise session leads to an 
improvement in insulin sensitivity that has been shown to last for one to two days. This can be 
quickly canceled by two days of no physical activity. Therefore, regular physical activity is 
needed in order to maintain the augmented insulin sensitivity. In both IDDM and NIDDM, 
insulin supplementation may need to be decreased as the duration of exercise increases. In the 
NIDDM, the insulin treatments are more likely to be discontinued due to this increased sensitivity 
to insulin. In addition to this, long term diabetic control is more likely to occur with NIDDM 
than with IDDM. 
Regular aerobic exercise not only affects insulin and glucose levels, but it also reduces 
obesity. By reducing one of the factors that contributes to NIDDM, there is a greater chance that 
the diease can be controlled. It has been shown many times that a reduction in weight to a 
desirable level correlates with a decrease and sometimes a halt to the symptoms of NIDDM. This 





With proper diet, aerobic exercise, and proper medical attention diabetes can be controlled. 
It is when the symptoms are ignored that problems arise with a greater frequency and severity. 
All problems can not be avoided, as they can happen to the most controlled case. Yet, it can only 
add to the life expectancy of the diabetic if these are understood and considered. In an effort to 
enhance this knowledge of patients on a general level I have addressed some of the major points 
of this serious disorder. It is still a wise idea to investigate any disease in an order to understand 
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